Verona Pharma said on Monday that, after the 50 for 1 share consolidation approved by shareholders on 8 February 2017, it now has 51,361,064 ordinary shares of £0.05 each in issue, each carrying one voting right.
Verona Pharma has a block listing issued in respect of Ordinary Shares which may arise pursuant to the exercise of warrants issued in connection with the placing completed in July 2016. According to an interim update, there are 10,262,879 of the newly consolidated Ordinary Shares which are currently block listed.